Escalon Medical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022
For the six months, revenue was USD 5.61 million compared to USD 5.38 million a year ago. Net loss was USD 0.326767 million compared to net income of USD 0.264066 million a year ago. Basic loss per share from continuing operations was USD 0.05 compared to basic earnings per share from continuing operations of USD 0.03 a year ago. Diluted loss per share from continuing operations was USD 0.05 compared to diluted earnings per share from continuing operations of USD 0.02 a year ago.